Early Onset Neonatal Sepsis Pathogens in Malaysian Hospitals: Determining Empiric Antibiotic

Information regarding early onset neonatal sepsis
(EONS) pathogens may vary between regions. Global perspectives
showed Group B Streptococcal (GBS) as the most common causative
pathogens, but the widespread use of intrapartum antibiotics has
changed the pathogens pattern towards gram negative
microorganisms, especially E. coli. Objective of this study is to
describe the pathogens isolated, to assess current treatment and risk
of EONS. Records of 899 neonates born in three General Hospitals
between 2009 until 2012 were retrospectively reviewed. Proven was
found in 22 (3%) neonates. The majority was isolated with gram
positive organisms, 17 (2.3%). All grams positive and most gram
negative organisms showed sensitivity to the tested antibiotics. Only
two rare gram negative organisms showed total resistant. Male was
possible risk of proven EONS. Although proven EONS remains
uncommon in Malaysia, nonetheless, the effect of intrapartum
antibiotics still required continuous surveillance.





References:
[1] L. A-B Ann. et al., "Neonatal Sepsis,” Retrieved September 3, 2011
from http://emedicine.medscape.com/article/978352-overview, 2011.
[2] S. Vergnano, M. Sharland, P. Kazembe,. and C. P. T. Mwansambo,
"Heath Neonatal sepsis: an international perspective,” Archives of
Disease in Childhood. Fetal Neonatal, Edition, 2005, 90, F220–F224.
[3] W.E. Benitz, J.B. Gould, and M.L. Druzin, "Antimicrobial prevention of
early-onset Group B Streptococcal Sepsis: Estimates of risk reduction
based on a critical literature review” Journal of the American Academy
of Pediatrics, 1999, 103, e78.
[4] S. Kenyon, M. Boulvain and J. Neilson, "Antibiotics for preterm rupture
of membranes (Review),” Cochrane Database of Systematic Review,
2007, 4, CD001058.
[5] T. Siriwachirachai, ,U.S. Sangkomkamhang, P. Lumbiganon, and M.
Laopaiboon, "Antibiotics for meconium-stained amniotic fluid in labour
for preventing maternal and neonatal infections (Review),” Cochrane
Database System Review, 2010, 12, CD007772.
[6] C. H. Raynes-Greenow, C. L Roberts, J. C. Bell, B. Peat, G. L. Gilbert
and S. Parker, " Antibiotics for ureaplasma in the vagina in pregnancy
(Review),” Cochrane Database of Systematic Review, 2011, 9,
CD003767.
[7] J.R. Verani, L. McGee and S.J. Schrag, "Prevention of perinatal group B
streptococcal disease-revised guigelines from CDC, 2010. Division of
Bacterial Diseases, national Center for Immunization and Respiratory
Diseases, Center for Disease Control and Prevention (CDC),” MMWR
Recomm Rep 2010, 59 (RR-10):1-36.
[8] ACOG, Committee opinion, "Prevention of early-onset group B
streptococcal disease in newborns,” The American College of
Obstetricians and Gynecologists, 2011,485.
[9] E.I. Mtitimila and R.W. Cooke, "Antibiotic regimens for suspected early
neonatal sepsis,” Cochrane Database of Systematic Review, 2004,
CD004495.
[10] R.H. Clark, B.T. Bloom, A.R. Spitzer and D.R. Gerstmann, "Empiric
use of ampicillin and cefotaxime, compared with ampicillin and
gentamicin, for neonates at risk for sepsis is associated with an increased
risk of neonatal death,” Journal of the American Academy of Pediatrics,
2006, 117, 67-74.
[11] T. Metsvaht, M-L. Ilmoja, Ü. Parm, L. Maipuu, M. Merila and I. Lutsar,
"Comparison of ampicillin plus gentamicin vs. penicillin plus
gentamicin in empiric treatment of neonates at risk of early onset
sepsis,” Acta Paediatrica , 2010, 99, 665-672.
[12] J. S. Schrag, J. L. Hadler, K.E. Arnold, P. Martell-Cleary, A. Reingold,
and A. Schuchat, " Risk factors for invasive, early onset Escherichia coli
infections in the era of widespread intrapartum antibiotic use,” Journal
of the American Academy of Pediatrics, 2006, 118, 570-576.
[13] M.J. Bizzarro, L-M. Dembry, R.S. Baltimore and P.G. Gallagher,
"Changing patterns in neonatal Escherichia coli sepsis and the
ampicillin resistance in the era of intrapartum antibiotic prophylaxis,”
Journal of the American Academy of Pediatrics, 2008, 121, 689-696.
[14] M.P. Weinstein, "Blood culture contamination: Persisting problems and
partial progress,” Journal of Clinical Microbiology, 2003, 41,6,2275-
2278.
[15] J.S. Gerdes, "Diagnosis and management of bacterial infections in the
neonate,” Journal of Pediatric Clinical of Noth America, 2004, 51, 939-
959.
[16] R.Y. Bhat, and L.P. Baby, "Early onset of neonatal sepsis: analysis the
risk factors and the bacterial isolated by using the BacT alert system,”
Journal of Clinical and Diagnostic Research, 2011, 5,7,1385-1388.
[17] WHO, 17th Expert Committee on the Selection and Use of Essential
Medicines, "Review of the efficacy and safety of procaine
benzylpenicillin in neonates,” 2009.
[18] B.J. Stoll, N.I. Hansen, R.D. Higgins, A.A. Fanaroff, S. Duara, R.
Goldberg, A. Laptook, M. Walsh, W. Oh and E. Hale, "Very low birth
weight preterm infants with early onset neonatal sepsis: The
predominance of gram negative infections continues in the National
Institute of Child Health and Human Development Neonatal Research
Network, 2002-2003,” The Pediatric Infection Disease Journal, 2005,
24, 635-639.
[19] N.E. Glass, J. Sculkin, S. Chamany, L.E. Riley, A. Schuchat and S.
Schrag, "Opportunities to reduce overuse of antibiotics for perinatal
group B streptococcal disease prevention and management of preterm
premature rupture of membranes,” Infectious Diseases in Obstetrics and
Gynecology, 2005, 13,1,5-10.
[20] S. Schrag, R. Gorwitz, K. Fultz-Butts, and A. Scuchat, "Prevention of
perinatal group B streptococcal disease. Revised guidelines from CDC,”
MMWR Recommendations and Reports, 2002, 51(RR-11):1-22.
[21] M.R. Moore, S.J. Schrag and A. Schuchat, "Effects of intrapartum
antimicrobial prophylaxis for prevention of group B streptococcal
disease on the incidence and ecology of early onset neonatal sepsis,” The
Lancet Infectious Diseases, 2003, 3,201-213.
[22] B.J. Stoll, N. Hansen, A. Fanaoff, L.L. Wright, W.A. Carlo, R.A.
Ehrenkranz, J.A. Lemons, E.F. Donovan, A.R. Stark, J.E. Tayson, W.
Oh, C. R. Bauer, S.B. Korones, S. Shankaran, A.R. Laptook, D.K.
Stevenson, L-A. Papile and K. Poole, "Changes in pathogens causing Early-Onset Sepsis in very-low-birth-weight infants,” New England
Journal of Medicine, 2002, 347, 240-247.
[23] P. Kuhn, C. Dheu, B. C olender, D. Chognot, L. Keller, H. Demil, L.
Donato, B. Langer, J. Messer and D. Astruc, "Incidence and distribution
of pathogens in early onset neonatal sepsis in the era of antenatal
antibiotics,” Paediatric and Perinatal Epidemiology, 2010, 24,479-487.
[24] C.H. Tsai, Y.Y. Chen, K.G. Wang, C.Y. Chen and C.P. Chen,
"Characteristics of early onset sepsis caused by Escherichia coli,”
Taiwanese Journal of Obstetrics & Gynecology, 2011 51,26-30.
[25] R. Ghotaslou, Z. Ghorashi and M-R. Nahaei, "Klebsiella pneumonia in
neonatal sepsis: A 3 year study in the Pediatric Hospital of Tabriz, Iran,
2007, 60,126-128.
[26] J.M. Andrews, "Determination of minimum inhibitory concentrations,”
Journal of Antimicrobial Chemotherapy, 2001, 48,S1,5-16.
[27] C.M. Muvunyi, F. Masaisa, C. Bayingana, L. Mutesa, A. Musemakweri,
G. Muhirwa and G. (W.) Claeys, "Decreased susceptibility to commonly
used antimicrobial agents in bacterial pathogens isolated from urinary
tract infections in Rwanda: Need for new antimicrobial guidelines,”
American Journal of Tropical Medicine and Hygiene, 2011, 84,6,923-
928.
[28] H. Gazi, S. Kurutepe, S. Surucuoglu, A. Teker, and B. Ozbakkaloglu,
"Antimicrobial susceptibility of bacterial pathogens in the oropharynx of
healthy school children in Turkey,” Indian Journal of Medical Research,
2004, 120,489-494.
[29] A. Nerurkar, P. Solanky and S.S. Naik, "Bacterial pathogens in urinary
tract infection and antibiotic susceptibility pattern,” Journal of
Pharmaceutical and Biomedical Sciences, 2012, 21,21,1-3.
[30] M. .Radji, Siti Fauziah and N. Aribinuko, "Antibiotic sensitivity pattern
of bacterial pathogens in the intensive care unit of Fatmawati Hospital,
Indonesia,” Asian Pacific Journal of Tropical Biomedicine, 2011,
1,1,39-42.
[31] I. Shaifali, U. Gupta, S.E. Mahmood and J. Ahmed, "Antibiotic
susceptibility patterns of urinary pathogens in female outpatients,” North
American Journal of Medical Sciences, 2012, 4,4,163-169.
[32] E. Saez-Lopez, E. Guiral and S.M. Soto, "Neonatal sepsis by bacteria: A
big problem for children,” Clinical Microbiology, 2013, 2,6,1000125.
[33] National Antibiotic Guideline. Malaysia: Ministry of Health, 2008. Page
181.
[34] A.I. Nazedah, M.M. Mohamed, and A.A. Noorizan, "The Effectiveness
of empiric antibiotic therapy in the prevention of early onset sepsis,”
International Journal of Current Research, 2014, 4,6258-6265.